Datroway

Indicated For

HR-positive HER2-negative breast cancer, NSCLC

About This Medication

# Daiichi Sankyo AccessCentral4U Patient Assistance Program Patient Guide: How to Get Datroway (datopotamab deruxtecan-dlnk) at Low or No Cost Datroway (datopotamab deruxtecan-dlnk) is a targeted therapy medication used to treat certain types of advanced cancer, such as non-small cell lung cancer or breast cancer, by delivering chemotherapy directly to cancer cells with a special antibody-drug conjugate technology. The **Daiichi Sankyo AccessCentral4U Patient Assistance Program** helps eligible patients like you get **Datroway** at no cost if you're uninsured, underinsured, or on Medicare and facing financial hardship. ## Who Qualifies for the Program? This program is designed for patients who need help affording their Daiichi Sankyo medications, including **Datroway**. You may qualify if you meet these key criteria: - **Financial need**: You're experiencing difficulty paying for your medication. - **Insurance status**: Uninsured, underinsured (limited coverage that doesn't fully cover costs), or Medicare patients. - **No strict income limits**: Unlike many programs, there are **no specific income thresholds** (e.g., no Federal Poverty Level percentage requirements). Eligibility is based on individual financial circumstances rather than a fixed income chart. This makes it more accessible for a wider range of patients in hardship. **Important note**: A separate commercial savings program is available for insured patients without income requirements, offering copay assistance. ## About Datroway (datopotamab deruxtecan-dlnk) **Datroway** is an innovative antibody-drug conjugate (ADC) approved for treating specific cancers in adults. It works by targeting cancer cells expressing TROP2 protein, delivering a potent chemotherapy payload directly to tumors while sparing healthy cells. Common uses include previously treated non-small cell lung cancer (NSCLC) and hormone receptor-positive, HER2-negative breast cancer. It's administered via intravenous infusion every 3 weeks in a clinical setting. **Potential side effects** include fatigue, nausea, hair loss, low blood counts, lung issues, and infusion reactions—always discuss with your doctor. As a newer therapy, it's often expensive without assistance, which is why programs like AccessCentral4U exist. ## Income Eligibility Breakdown Great news: This program **does not use rigid income thresholds**. Instead, eligibility focuses on your overall financial situation and inability to pay. Here's a simple table summarizing: | Household Size | Income Threshold | Notes | |---------------|------------------|-------| | Individual | None | Assessed case-by-case for financial hardship. | | Couple | None | No FPL limits; proof of income required to show need. | | Family of 3 | None | Medicare patients also eligible if facing costs. | | Family of 4 | None | Underinsured welcome—no strict cutoffs. | | FPL % | N/A | Focus on financial difficulty, not percentiles. | If your income is higher but you still can't afford **Datroway** due to other expenses, you may still qualify. Call to discuss your situation. ## Insurance Requirements - **Eligible**: Uninsured, underinsured, or Medicare patients having financial difficulty. - **Not eligible**: Patients with adequate commercial insurance coverage (use the commercial copay savings card instead). - The program provides **Datroway at no cost** to approved patients, bridging gaps in coverage. ## Step-by-Step Application Process Applying is straightforward with multiple options. Start by gathering documents and involving your doctor's office. 1. **Check eligibility**: Visit [https://www.dsaccesscentral4u.com](https://www.dsaccesscentral4u.com) or call **(855) 328-7648** (Mon-Fri, 8 AM-6 PM ET). Note: You may also see 1-866-437-4669 listed. 2. **Gather required documents**: - Proof of residency (e.g., utility bill, driver's license). - Proof of income (e.g., tax returns, pay stubs, SSI/SSDI letters). - Valid prescription for **Datroway**. - Physician signature on the application form. 3. **Submit application**: - **Online**: Use the website portal. - **Phone**: Call the number above for guided assistance. - **Fax/Mail**: Download forms from the site and send to the provided address. - Your doctor or their staff can submit on your behalf—AccessCentral4U works directly with healthcare providers. 4. **Benefits verification**: Case managers help verify insurance and handle prior authorizations if needed. 5. **Approval notification**: You'll be contacted with status updates. ## Timeline and Delivery - **Processing time**: Varies; expect 1-2 weeks typically, but call for your specific case as no fixed timeline is published. - **Delivery**: Medication is **shipped free to your home or doctor's office**. - **Reauthorization**: Required periodically (e.g., every 3-12 months) to confirm ongoing eligibility—your doctor will handle refill prescriptions. ## Alternatives if Denied or Ineligible - **Commercial Savings Program**: For insured patients—reduces copays to $0-$5 (check site for **Datroway**). - **Partnership for Prescription Assistance (PPA)**: Daiichi Sankyo participates; visit www.pparx.org to find other programs. - **State assistance**: Check Medicaid, state pharmaceutical aid, or 340B clinics. - **Appeals**: If denied, request a review with additional financial proof—case managers provide appeal templates. - **No biosimilars**: None available for **Datroway** yet. ## Important Disclaimer This guide is for informational purposes only and based on program details as of March 2026. Eligibility, terms, and availability can change—always verify directly with Daiichi Sankyo AccessCentral4U at (855) 328-7648 or [https://www.dsaccesscentral4u.com](https://www.dsaccesscentral4u.com). Not affiliated with government programs. Consult your healthcare provider before starting **Datroway**. Daiichi Sankyo reserves the right to modify or end the program. Word count: 952.

Program information last verified: March 30, 2026